Clinical Trials Directory

Trials / Completed

CompletedNCT00700531

European Trial of Free Light Chain Removal by Extended Haemodialysis in Cast Nephropathy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
90 (actual)
Sponsor
University Hospital Birmingham · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Hypothesis: Free light chain removal haemodialysis will increase the rate of renal recovery in patients with cast nephropathy, severe renal failure and de novo multiple myeloma. This study will randomise patients with multiple myeloma and severe renal failure to treatment to remove free light chains by haemodialysis or not.

Detailed description

The EUropean trial of free LIght chain removal by exTEnded haemodialysis in cast nephropathy (EuLITE) trial is a prospective, randomised, multicentre, open label clinical trial to investigate the clinical benefit of FLC removal haemodialysis in patients with cast nephropathy, dialysis dependent renal failure and de novo multiple myeloma. Recruitment commenced in May 2008, in total 90 patients will be recruited. Participants will be randomised, centrally, upon enrolment, to either trial chemotherapy and FLC removal haemodialysis or trial chemotherapy and standard high flux haemodialysis. Trial chemotherapy is a modified PAD regime, consisting of bortezomib, doxorubicin and dexamethasone. FLC removal haemodialysis is undertaken using two Gambro HCO 1100 dialysers in series, over an intensive treatment schedule. The primary outcome for the study is independence of dialysis at 3 months. Secondary outcomes are: duration of dialysis, reduction in serum FLC concentrations; myeloma response and survival.

Conditions

Interventions

TypeNameDescription
DEVICEFLC removal HD (Gambro HCO 1100)FLC removal HD using a extended dialysis schedule on the Gambro HCO 1100
PROCEDUREStandard dialysis on a high flux ployflux dialyserStandard dialysis on a high flux ployflux dialyser at a frequency determined by the duty nephrologist

Timeline

Start date
2008-06-01
Primary completion
2014-01-01
Completion
2015-10-01
First posted
2008-06-18
Last updated
2016-10-05

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT00700531. Inclusion in this directory is not an endorsement.